Proficio Capital Partners LLC Makes New $283,000 Investment in National Research Co. (NASDAQ:NRC)

Proficio Capital Partners LLC purchased a new stake in shares of National Research Co. (NASDAQ:NRCFree Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 16,035 shares of the company’s stock, valued at approximately $283,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. FMR LLC boosted its holdings in shares of National Research by 397.3% in the third quarter. FMR LLC now owns 2,944 shares of the company’s stock worth $67,000 after buying an additional 2,352 shares during the last quarter. Point72 Asset Management L.P. bought a new position in National Research in the third quarter worth approximately $88,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of National Research during the 3rd quarter worth $96,000. SG Americas Securities LLC boosted its stake in shares of National Research by 35.0% during the 4th quarter. SG Americas Securities LLC now owns 7,298 shares of the company’s stock worth $129,000 after acquiring an additional 1,893 shares during the last quarter. Finally, Quest Partners LLC grew its position in shares of National Research by 45,175.0% during the 3rd quarter. Quest Partners LLC now owns 9,055 shares of the company’s stock valued at $207,000 after acquiring an additional 9,035 shares during the period. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

National Research Price Performance

Shares of National Research stock opened at $13.94 on Thursday. The stock has a market cap of $319.87 million, a P/E ratio of 13.28 and a beta of 0.47. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. The stock’s fifty day moving average is $16.06 and its 200 day moving average is $18.15. National Research Co. has a one year low of $13.63 and a one year high of $39.98.

National Research (NASDAQ:NRCGet Free Report) last posted its quarterly earnings data on Monday, January 27th. The company reported $0.28 EPS for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.

National Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 3.44%. The ex-dividend date is Friday, March 28th. National Research’s payout ratio is 45.71%.

National Research Profile

(Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Featured Articles

Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRCFree Report).

Institutional Ownership by Quarter for National Research (NASDAQ:NRC)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.